Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Szu-Ting Yang

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Taiwanese Journal of Obstetrics & Gynecology|January 10, 2025
Primary cytoreductive surgery for advanced epithelial ovarian cancer patients is still popular in gynecologic oncologists in Korea and Taiwan, particularly apparent in TaiwanPeng-Hui Wang, Szu-Ting Yang, Jae-Weon Kim
Taiwanese Journal of Obstetrics & Gynecology|July 14, 2024
Sentinel-lymph-node mapping in endometrial cancer: Tumor location matters?Chia-Hao Liu, Szu-Ting Yang, Peng-Hui Wang
Taiwanese Journal of Obstetrics & Gynecology|July 14, 2024
The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practicePeng-Hui Wang, Szu-Ting Yang, Chia-Hao Liu
Taiwanese Journal of Obstetrics & Gynecology|May 14, 2025
The frontiers in gynecologic cancer management: Exploring the new hope to manage women with endometrial cancer by immunochemotherapyPeng-Hui Wang, Szu-Ting Yang, Byoung-Gie Kim
Taiwanese Journal of Obstetrics & Gynecology|May 14, 2025
Complex tumor microenvironment of endometrial cancerSzu-Ting Yang, Che-Wei Chang, Peng-Hui Wang
Journal of the Chinese Medical Association : JCMA|June 3, 2025
Winners of the 2022 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part ISzu-Ting Yang, Chia-Hao Liu, Peng-Hui Wang
Journal of the Chinese Medical Association : JCMA|January 18, 2023
Neoadjuvant therapyPeng-Hui Wang, Szu-Ting Yang, Chia-Hao Liu
Taiwanese Journal of Obstetrics & Gynecology|September 11, 2025
Mismatch repair (MMR) status detection is the first step for endometrial cancer patientsPeng-Hui Wang, Szu-Ting Yang, Wen-Hsun Chang
Taiwanese Journal of Obstetrics & Gynecology|September 11, 2025
Endometrial cancer: Mismatch repair proficient (MMRp) with TP53 protein mutationsPeng-Hui Wang, Szu-Ting Yang, Jen-Ruei Chen
Journal of the Chinese Medical Association : JCMA|September 15, 2025
Management of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer patients: First-line therapyPeng-Hui Wang, Szu-Ting Yang, Wen-Hsun Chang
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Taiwanese Journal of Obstetrics & Gynecology|January 10, 2025
Primary cytoreductive surgery for advanced epithelial ovarian cancer patients is still popular in gynecologic oncologists in Korea and Taiwan, particularly apparent in TaiwanPeng-Hui Wang, Szu-Ting Yang, Jae-Weon Kim
Taiwanese Journal of Obstetrics & Gynecology|July 14, 2024
Sentinel-lymph-node mapping in endometrial cancer: Tumor location matters?Chia-Hao Liu, Szu-Ting Yang, Peng-Hui Wang
Taiwanese Journal of Obstetrics & Gynecology|July 14, 2024
The selection of immune checkpoint inhibitors of programmed cell death (anti-PD-1) and its ligand (anti-PD-L1) makes matters more challenges for clinical practicePeng-Hui Wang, Szu-Ting Yang, Chia-Hao Liu
Taiwanese Journal of Obstetrics & Gynecology|May 14, 2025
The frontiers in gynecologic cancer management: Exploring the new hope to manage women with endometrial cancer by immunochemotherapyPeng-Hui Wang, Szu-Ting Yang, Byoung-Gie Kim
Taiwanese Journal of Obstetrics & Gynecology|May 14, 2025
Complex tumor microenvironment of endometrial cancerSzu-Ting Yang, Che-Wei Chang, Peng-Hui Wang
Journal of the Chinese Medical Association : JCMA|June 3, 2025
Winners of the 2022 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part ISzu-Ting Yang, Chia-Hao Liu, Peng-Hui Wang
Journal of the Chinese Medical Association : JCMA|January 18, 2023
Neoadjuvant therapyPeng-Hui Wang, Szu-Ting Yang, Chia-Hao Liu
Taiwanese Journal of Obstetrics & Gynecology|September 11, 2025
Mismatch repair (MMR) status detection is the first step for endometrial cancer patientsPeng-Hui Wang, Szu-Ting Yang, Wen-Hsun Chang
Taiwanese Journal of Obstetrics & Gynecology|September 11, 2025
Endometrial cancer: Mismatch repair proficient (MMRp) with TP53 protein mutationsPeng-Hui Wang, Szu-Ting Yang, Jen-Ruei Chen
Journal of the Chinese Medical Association : JCMA|September 15, 2025
Management of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer patients: First-line therapyPeng-Hui Wang, Szu-Ting Yang, Wen-Hsun Chang
Pageof 14